INT71424

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.17
First Reported 1997
Last Reported 1997
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 2
Disease Relevance 0
Pain Relevance 0.48

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Pyy) extracellular region (Pyy)
Pyy (Rattus norvegicus)
Pain Link Frequency Relevance Heat
tetrodotoxin 2 99.80 Very High Very High Very High
lidocaine 2 98.64 Very High Very High Very High
antagonist 2 89.92 High High

|}

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The inhibitory effect of peptide YY was suppressed, or strongly and significantly reduced, by tetrodotoxin, hexamethonium, lidocaine, idazoxan and BMY14,802 (51-(4-fluorophenyl)-4-(-4-(5-fluoro-2pyrimidinyl)-1-piperazinyl)- 1-butanol), whereas devazepide and L-NAME (L-omega-N-arginine methyl ester) had no effect.
Negative_regulation (reduced) of Negative_regulation (effect) of peptide YY associated with tetrodotoxin and lidocaine
1) Confidence 0.17 Published 1997 Journal Eur. J. Pharmacol. Section Abstract Doc Link 9311665 Disease Relevance 0 Pain Relevance 0.24
The inhibitory effect of peptide YY was suppressed, or strongly and significantly reduced, by tetrodotoxin, hexamethonium, lidocaine, idazoxan and BMY14,802 (51-(4-fluorophenyl)-4-(-4-(5-fluoro-2pyrimidinyl)-1-piperazinyl)- 1-butanol), whereas devazepide and L-NAME (L-omega-N-arginine methyl ester) had no effect.
Negative_regulation (suppressed) of Negative_regulation (effect) of peptide YY associated with tetrodotoxin and lidocaine
2) Confidence 0.17 Published 1997 Journal Eur. J. Pharmacol. Section Abstract Doc Link 9311665 Disease Relevance 0 Pain Relevance 0.24

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox